Contribution of Proline Residue for Efficient Production of MHC Class I Ligands by Proteasomes*

Proteasomes are processing enzymes capable of generating major histocompatibility complex (MHC) class I ligands, but the mechanism of how they excise ligands without destroying them is largely unknown. Previously, we reported that most products of ornithine decarboxylase degraded in vitro by the 26 S ATP-dependent proteasome, which contained one or two Pro residues (Tokunaga, F., Goto, T., Koide, T., Murakami, Y., Hayashi, S., Tamura, T., Tanaka, K., and Ichihara, A. (1994) J. Biol. Chem. 269,17382–17385), which implied that the Pro residue has a role in the escape from random cleavage by proteasomes. Here, we examine the role of the Pro residue in producing MHC class I ligands in vitro. Proteasomes generated two cytotoxic T lymphocyte-epitopic precursor peptides, SIIPGLPLSL and DMYPHFMPTNL, from the 29-mer and 25-mer peptides harboring these sequences, which are derived from the c-akt proto-oncogene and the pp89 protein of mouse cytomagalovirus, respectively. Replacement of the first or second Pro residue within these epitopes by Ala resulted in a marked reduction of this epitope-derived production or their random cleavage by proteasomes, irrespective of the presence of PA28, which greatly accelerates the generation of unmodified ligands. Moreover, replacement of a single amino acid residue other than Pro in both epitopic and flanking regions by Ala or Leu had no or little appreciable effect on the SIIPGLPLSL or its derivative production. Thus, Pro residue(s) within these epitopic sequences presumably contributes to efficient production of MHC class I ligands through prevention of their random cleavage by proteasomes.

[1]  C. Slaughter,et al.  Primary structures of two homologous subunits of PA28, a γ‐interferon‐inducible protein activator of the 20S proteasome , 1995, FEBS letters.

[2]  P. Kloetzel,et al.  The Interferon-γ-inducible 11 S Regulator (PA28) and the LMP2/LMP7 Subunits Govern the Peptide Production by the 20 S Proteasome in Vitro(*) , 1995, The Journal of Biological Chemistry.

[3]  Y. Murakami,et al.  ATP- and antizyme-dependent endoproteolysis of ornithine decarboxylase to oligopeptides by the 26 S proteasome. , 1994, The Journal of biological chemistry.

[4]  Vladimir Brusic,et al.  MHCPEP, a database of MHC-binding peptides: update 1996 , 1997, Nucleic Acids Res..

[5]  H. Wada,et al.  Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5' region of the c-akt proto-oncogene activated by long terminal repeat. , 1995, Cancer research.

[6]  K Eichmann,et al.  Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.

[7]  Wolfgang Baumeister,et al.  Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System , 1997 .

[8]  C. Slaughter,et al.  Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). , 1992, The Journal of biological chemistry.

[9]  C. Hahn,et al.  The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen , 1996, The Journal of experimental medicine.

[10]  J. Monaco,et al.  The genetics of proteasomes and antigen processing. , 1995, Annual review of genetics.

[11]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.

[12]  Hans-Georg Rammensee,et al.  A role for the proteasome regulator PA28α in antigen presentation , 1996, Nature.

[13]  R. Tampé,et al.  Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides. , 1996, European journal of biochemistry.

[14]  K. Rock,et al.  Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.

[15]  Hans-Georg Rammensee,et al.  Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.

[16]  J. Neefjes,et al.  Peptide selection by MHC-encoded TAP transporters. , 1994, Current opinion in immunology.

[17]  T. Yasuda,et al.  Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene , 1994, The Journal of experimental medicine.

[18]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[19]  P. Kloetzel,et al.  The cleavage preference of the proteasome governs the yield of antigenic peptides , 1995, The Journal of experimental medicine.

[20]  K. Ferrell,et al.  Purification of an 11 S regulator of the multicatalytic protease. , 1992, The Journal of biological chemistry.

[21]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[22]  T. Fujiwara,et al.  Molecular properties of the proteasome activator PA28 family proteins and γ‐interferon regulation , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[23]  A. Ikai,et al.  Proteasomes (multi-protease complexes) as 20 S ring-shaped particles in a variety of eukaryotic cells. , 1988, The Journal of biological chemistry.

[24]  P M Kloetzel,et al.  A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. , 1996, Immunity.

[25]  U. Koszinowski,et al.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.

[26]  P. Cresswell,et al.  How selective is the transporter associated with antigen processing? , 1996, Immunity.

[27]  J. Neefjes,et al.  The proteasome‐specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells , 1997, European journal of immunology.

[28]  P M Kloetzel,et al.  Peptide antigen production by the proteasome: complexity provides efficiency. , 1996, Immunology today.

[29]  P M Kloetzel,et al.  Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes , 1994, The Journal of experimental medicine.

[30]  N. Tanahashi,et al.  Proteasomes and antigen processing. , 1997, Advances in immunology.

[31]  S. Matsufuji,et al.  Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination , 1992, Nature.

[32]  K. Rajewsky,et al.  MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.

[33]  H. Ploegh,et al.  Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.

[34]  A. Goldberg,et al.  Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Elliott,et al.  Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum , 1995, The Journal of experimental medicine.

[36]  J. Yewdell,et al.  Trimming of antigenic peptides in an early secretory compartment , 1994, The Journal of experimental medicine.

[37]  A. Goldberg,et al.  Lactacystin and clasto-Lactacystin β-Lactone Modify Multiple Proteasome β-Subunits and Inhibit Intracellular Protein Degradation and Major Histocompatibility Complex Class I Antigen Presentation* , 1997, The Journal of Biological Chemistry.

[38]  Keiji Tanaka,et al.  Double‐cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[39]  U. Koszinowski,et al.  Sequence and structural organization of murine cytomegalovirus immediate-early gene 1 , 1987, Journal of virology.